Florian Castet

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol et al. · Nature · 2021 · 1.2K citations · Full text

Life Sciences, Immunology, Oncology +17

Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification

Carla Montironi, Florian Castet, Philipp K. Haber et al. · Gut · 2022 · 236 citations · Full text

Medicine, Immunology, Oncology +16

Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma

Philipp K. Haber, Florian Castet, Miguel Torres‐Martín et al. · Gastroenterology · 2022 · 146 citations · Full text

Medicine, Cancer Biology, Oncology +16

Contrast-enhancement in supratentorial low-grade gliomas: a classic prognostic factor in the molecular age

Florian Castet, Enrique Alanya, Noemí Vidal et al. · Journal of Neuro-Oncology · 2019 · 44 citations

Medicine, Oncology, Radiology +16

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population

Margherita Rimini, Lorenzo Fornaro, Mario Domenico Rizzato et al. · European Journal of Cancer · 2024 · 44 citations · Full text

Medicine, Oncology, Pharmacology +13